NDC 51662-1242
NALOXONE HCI
Naloxone Hci
NALOXONE HCI is a Intramuscular; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Health First. The primary component is Naloxone Hydrochloride.
| Product ID | 51662-1242_80625ecc-d6b5-74fc-e053-2991aa0a4776 |
| NDC | 51662-1242 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NALOXONE HCI |
| Generic Name | Naloxone Hci |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2018-08-18 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA070254 |
| Labeler Name | HF Acquisition Co. LLC, DBA Health First |
| Substance Name | NALOXONE HYDROCHLORIDE |
| Active Ingredient Strength | 0 mg/mL |
| Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |